ADC Bio’s new state of the art clean room facility is now ready to serve global customer demands!
Production of new anti-cancer drugs at ADC Bio’s North Wales manufacturing plant has been boosted following completion of a new cleanroom facility. The project has been designed and built by WHP.
The new GMP cleanroom is part of ADC Bio’s construction of a bioconjugation facility at its site in Deeside, North Wales (UK) for the commercial production of antibody-drug conjugates in response to global customer demand.
“We are building a best-in-class facility to the highest possible global standards,” said Charlie Johnson, CEO at ADC Bio. “We awarded the contract to WHP on the back of its relevant industry experience and reputation for delivering cost-effective, single-source cleanroom design and build packages,” he added.
For more information please follow the link.